Clinical trial
Evaluation of Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
NCT00481429 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 31, 2007
- Completion date
- January 31, 2008
- Enrollment
- 0 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.